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Abstract
Background: Collagen-like surface proteins Scl1 and Scl2 on Streptococcus pyogenes contain contiguous Gly-X-X
triplet amino acid motifs, the characteristic structure of human collagen. Although the potential role of Scl1 in
adhesion has been studied, the conclusions may be affected by the use of different S. pyogenes strains and their
carriages of various adhesins. To explore the bona fide nature of Scl1 in adherence to human epithelial cells
without the potential interference of other streptococcal surface factors, we constructed a scl1 isogenic mutant
from the Scl2-defective S. pyogenes strain and a Scl1-expressed Escherichia coli.
Results: Loss of Scl1 in a Scl2-defective S. pyogenes strain dramatically decreased the adhesion of bacteria to HEp-2
human epithelial cells. Expression of Scl1 on the surface of the heterologous bacteria E. coli significantly increased
adhesion to HEp-2. The increase in adhesion was nullified when Scl1-expressed E. coli was pre-incubated with
proteases or antibodies against recombinant Scl1 (rScl1) protein. Treatment of HEp-2 cells with rScl protein or
pronase drastically reduced the binding capability of Scl1-expressed E. coli. These findings suggest that the
adhesion is mediated through Scl1 on bacterial surface and protein receptor(s) on epithelial cells. Further blocking
of potential integrins revealed significant contributions of a2 and b1 integrins in Scl1-mediated binding to
epithelial cells.
Conclusions: Together, these results underscore the importance of Scl1 in the virulence of S. pyogenes and
implicate Scl1 as an adhesin during pathogenesis of streptococcal infection.
Background
Streptococcus pyogenes causes heterogeneous disease
types, including pharyngitis, cellulitis, and bacteremia
[1]. The pathogenesis of S. pyogenes infection involves
an intriguing host-pathogen interplay in which the bio-
logical activity of several bacterial virulence products are
modulated by host factors [2]. The details of the mole-
cular interaction between the bacterium and the host, as
well as their influences on the prognosis and severity of
streptococcal infection, remain poorly understood. S.
pyogenes has been reported to produce a number of sur-
face-associated and extracellular products contributing
to the pathogenesis. In particular, several cell surface
proteins have been documented as being involved in
adherence and colonization during infection [3].
Many cell surface proteins of gram-positive bacteria
share similar structural characteristics that include a
variable amino terminus, a central region with repeated
sequences, and a cell-associated region with a LPXTGX
cell wall anchored motif [4]. A new S. pyogenes cell sur-
face protein family, streptococcal collagen-like (Scl) pro-
tein, has been identified recently [5-10]. Scl1 (SclA) and
Scl2 (SclB), two Scl protein family members, share a
similar structure motif, including the LPXTGX motif
and a central region composed of variable numbers of
Gly-X-X (GXX) collagen-like motifs. Collagen exhibits a
triple-helical, elongated protein structure that is the
structural component of the extracellular matrix in mul-
ticellular organisms. As eukaryotic cells are known to
bind to collagen through receptors expressed on cell
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any medium, provided the original work is properly cited.surfaces [11], it is reasonable to speculate that the Scl
protein family may participate in the colonization/bind-
ing of S. pyogenes to receptors on the host cell.
Although the potential role of Scl1 in adhesion has been
demonstrated by disrupting the scl1 gene in different S.
pyogenes strains [5,6], the conclusions may be affected
by the use of different S. pyogenes strains and their car-
riages of various adhesins. In addition, the presence of
other Scl family proteins, as well as other streptococcal
surface proteins, which may mask the potential role of
Scl1 in adhesion, was not taken into consideration in
these studies.
Recent studies have demonstrated that collagen recep-
tor, a2b1 and a11b1 integrins [9,12,13], low density lipo-
protein [14], thrombin-activatable fibrinolysis inhibitor
[15], cellular fibronectin and laminin [16] and human
complement regulatory plasma glycoprotein FH [17] may
serve as ligands for Scl proteins. While the scl1 gene has
been found in all S. pyogenes isolates tested, the scl2 gene
sequence was only detected in some strains [7,10,18]. To
determine the bona fide nature of Scl1 in colonization
and adherence of S. pyogenes to human epithelial cells
without the potential interference of other streptococcal
surface factors, we generated a scl1 mutant from a Scl2-
defective S. pyogenes M29588 strain, and expressed Scl1
in the heterologous bacteria Escherichia coli.T h ea d h e -
sion to human epithelial cells was greatly impaired upon
t h el o s so fS c l 1i nS. pyogenes and was markedly
increased upon expression of Scl1 on E. coli.
Results
Identification and analysis of scl1 and scl2 genes in S.
pyogenes M29588 strain
To identify genes encoding streptococcal collagen-like
surface protein 1 and 2 (scl1 and scl2)i nS. pyogenes
M29588 strain, full lengths of scl1 and scl2 genes were
a m p l i f i e db yP C Ra n ds e q u e n c e d .T h escl1 ORF of S.
pyogenes M29588 is 1,287 bp, which encodes a protein
with 428 amino acid residues (Figure 1A). The Ala38
was the predicted signal peptidase cleavage site. The
length of variable (V) region is 71 amino acids. The col-
lagen-like (CL) region is composed of 46 GXX triplet
repeats, followed by a gram-positive bacteria cell wall
anchor motif (LPATGE) in the cell wall membrane
(WM) region. The CL region and cell wall anchor motif
are connected by 6 repeats with a PGEKAPEKS core
sequence in the linker (L) region.
It has been shown that the expression of Scl2 is con-
trolled by slipped-strand mispairing at sites containing
pentanucleotide coding repeats [7,10,18]. In this study,
S. pyogenes M29588 strain contained the scl2 gene,
which is predicted to be translated from a putative GTG
(Val) start codon (Figure 1B). We identified 13 AACAA
pentanucleotide sequence repeats adjacent to the
presumed GTG start codon in S. pyogenes M29588, fol-
lowed by a premature translation termination at the
89th amino acid residue upon production of Scl2 pro-
tein (Figure 1B). However, the prematurely translated
Scl2 protein contains neither CL region nor the anchor
motif, suggesting it is not functional and not anchored
on the bacteria. These observations show that the S.
pyogenes M29588 strain appears to express Scl1 protein
consisting of 46 GXX triplet repeats and premature
non-functional Scl2 protein.
Loss of adherence to human epithelial cells in S.
pyogenes mutant deficient in both Scl1 and Scl2
To determine the role of Scl1 in the adherence of S.
pyogenes to human epithelial cells in the absence of
Scl2, we generated a scl1 mutant from the Scl2-defective
S. pyogenes M29588 strain. A kanamycin-resistant
mutant (ST2) was identified after electroporation of S.
pyogenes M29588 with the non-replicating plasmid
pPJT8, which contains the internal fragment of the scl1
coding region. PCR and Southern blot analysis con-
firmed the site of mutation, and indicated that the inte-
gration occurred through a Campbell-like mechanism
(data not shown). No difference in growth rates between
the mutant and wild-type strains in TSBY was identified
(data not shown), suggesting that the disruption of scl1
did not affect major metabolic pathways under a nutri-
ent-enriched condition, and the integration of pPJT8 did
not affect the neighboring genes of scl1. To further clar-
ify if the mutagenesis strategy affected other surface fac-
tors, we determined the expression of fibronectin
binding proteins, sfb and prtF1, and another known
adhesin, oppA, as well as an exotoxin speB as the inter-
nal control (Figure 2A). Expression of these four genes
was not affected in the scl1 mutant ST2. These results
suggest that the mutagenesis strategy did not influence
other surface factors, and the scl1 mutant has not com-
pensated for the loss of this adhesin by altering expres-
sion profiles for other potential surface binding proteins
we tested. In addition, DNA sequence and the number
of pentanucleotide repeats of scl2 were not altered in
ST2 (data not shown).
To further investigate the role of Scl1 in mediating the
adherence of S. pyogenes to human epithelial cells, wild-
type and scl1-mutated S. pyogenes ST2, in the exponen-
tial phase, were examined for adhesion to human HEp-2
epithelial cells. Adhesion of ST2, was decreased about
70% compared with that of the wild-type (P < 0.01,
Figure 2B), suggesting that Scl1 is critical in the adher-
ence of S. pyogenes to human epithelial cells.
Ectopic expression of Scl1 on E. coli
To exclude the interference of other streptococcal sur-
face factors during the adhesion, and to test whether
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Figure 1 Nucleotide and inferred amino acid sequences of scl1 and scl2 genes in S. pyogenes M29588 strain (M92 type). (A) scl1 coding
sequence consists of 1,287 bp which encodes a protein with 428 amino acids. Scl1 protein is composed of signal sequence (SS) followed by a
predicted cleavage site (arrowhead), 71 amino acids in V region, 46 GXX triplet motifs (boxed) in CL region, and 6 PGEKAPEKS repeats
(underlined) in L region, and the LPATGE cell wall anchor motif (shaded) in WM region. (B) Scl2 protein is translated from the predicted GTG
start codon (Val). Thirteen AACAA coding repeats (boxed), located immediately after the GTG start codon, are followed by a premature
translation termination at the 89th amino acid residue (asteriated).
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Page 4 of 11Scl1 is sufficient to mediate the adherence to human
epithelium cells, we expressed Scl1 on the heterologous
bacteria E. coli. Signal sequence (SS), WM region, and
part of the L region of Scl1 were not constructed into
OmpA-containing vector. E. coli DH5a with OmpA-
containing vector was represented as ET2, whereas E.
coli DH5a with truncated Scl1-OmpA construct was
represented as ET3. To confirm the expression of Scl1
protein on the surface of E. coli,w ep e r f o r m e dF A C S
analysis on whole bacteria. A right-shift of peak fluores-
cence recognized by anti-Scl1 antibodies was observed
in ET3, but not in either E. coli DH5a or ET2. (Figure
3A). Consistent with this observation, the negative stain-
ing of electron microscopy revealed hairy structures in
ET3, but these structures were not identified in either E.
coli DH5a or ET2 (Figure 3B). To further demonstrate
that Scl1 was ectopically expressed on E. coli,o u t e r
membrane fraction of proteins was isolated from ET2
and ET3. Western blot analysis with anti-Scl1 antibodies
identified Scl1 in the outer membrane fraction of ET3
but not in that of ET2 (Left panel, Figure 3C). Consis-
tently, a molecular weight shift was revealed by anti-
OmpA antibodies in the outer membrane fraction of
ET3 (Right panel, Figure 3C). Thus, our data confirmed
that Scl1 protein was ectopically expressed on E. coli
and can be detected by anti-Scl1 antibodies.
Adherence of Scl1-expressed E. coli to human epithelial
cells
Adhesion analysis demonstrated that Scl1-expressed E.
coli ET3 dramatically increased its adherence to HEp-2,
compared with that of vector-expressed E. coli ET2 and
E. coli DH5a (Figure 4A). Pre-incubation of E. coli ET3
with proteinase K significantly attenuated the Scl1-
mediated increase in adhesion, suggesting that Scl1 pro-
teins on E. coli are critical for this binding. Thus, the
addition of Scl1 on the surface of the heterologous bac-
teria greatly enhances their adherence to human epithe-
lial cells.
To directly address the role of Scl1 in the binding
process, we performed competition studies using anti-
Scl1 antibodies and recombinant Scl1 (rScl1) protein.
Polyclonal anti-Scl1 antibodies were generated in
4-week-old BALB/c mice. The full-length rScl1 protein
containing sequences shown in Figure 1A was generated
and confirmed by SDS-PAGE as a single band of
approximately 48 kDa (Lane 1, Figure 4B) and by wes-
tern blot analysis with anti-Scl1 antibodies (Lane 2,
Figure 4B). Both pre-incubation of HEp-2 cells with
rScl1 and pre-incubation of ET3 bacteria with anti-Scl1
antibodies significantly blocked the adherence of E. coli
ET3 to human epithelial cells (Figure 4C). The adher-
ence of E. coli ET3 to HEp-2 cells was not affected by
pre-incubation of ET3 bacteria with non-specific mouse
IgG. These results reveal both the importance and suffi-
ciency of Scl1 in mediating the adherence of bacteria to
human epithelial cells.
A.                            B .  
              
Figure 2 Expression profile and adhesion ability of scl1-
mutated S. pyogenes. (A) mRNA levels in fibronectin binding
proteins (sfb and prtF1), olidopeptidase A (oppA), streptococcal
collagen-like proteins (scl1 and scl2), and exotoxin B (speB)a sa n
expression control. (B) HEp-2 cells were incubated with FITC-
conjugated wild-type (WT) and Scl1-mutated S. pyogenes (ST2). The
adhesion ability is expressed as the ratio of florescence from
adherent bacteria to that from inoculated bacteria. Data represent
means of five experiments with triplicate samples in each
experiment. **, P < 0.01 compared with S. pyogenes wild-type
M29588 strain.
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Figure 3 Ectopic expression of Scl1 on E. coli. (A) FACS analysis
on whole bacteria pre-incubated with (white profile) or without
(gray profile) anti-Scl1 antibodies, followed by FITC-conjugated
secondary antibodies. (B) Electron microscope view of whole
bacteria after negative staining with sodium phosphotungstate.
Asterisks indicate ectopic expressed Scl1 on the E. coli surface. Bars
represent 100 nm. ET2, E. coli expressing vector only. ET3, E. coli
expressing Scl1. (C) Western blot analysis with anti-Scl1 (left panel)
and anti-OmpA (right panel) antibodies in the outer membrane
fraction of ET2 and ET3.
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Page 5 of 11Adherence through protein receptor(s) on epithelial cells
Our previous data showed that the adhesion was
affected when Scl1-expressed E. coli was pre-incubated
with proteinase K, suggesting that the adhesion is
mediated through a protein-like molecule on the bac-
teria. To further determine the corresponding side of
surface molecules on epithelial cells mediating this bind-
ing process, HEp-2 cells were treated with pronase and
phospholipase A2 to modify the protein and lipid con-
tents on the cell membrane, respectively [19]. Treatment
of pronase significantly inhibited the binding of ET3 to
epithelial cells in a dose-dependent manner (Figure 5A).
In contrast, treatment of phospholipase A2 did not
affect the binding of ET3 to epithelial cells (Figure 5A).
These results suggest that a protein receptor for Scl1 on
epithelial cells is likely to mediate this binding event.
It has been proposed that a2b1a n da11b1 integrins
might serve as receptors in mediating the Scl1 adherence
to epithelial cells [9,12,13]. To determine the role of
integrins in the Scl1-mediated binding process, we used
monoclonal antibodies against a2, b1, and a2b1i n t e g -
rins, and performed a competition assay. Pretreatment of
monoclonal antibodies against a2, b1, and a2b1 integrins
to HEp-2 cells did not affect Scl1-mediated increase in
the adhesion of E. coli to human epithelial cells (Figure
5B). However, we observed a trend, although not signifi-
cant, toward reduction in the adhesion of E. coli to HEp-
2 cells in the presence of monoclonal a2b1 antibodies,
suggesting that a2b1 integrin is involved to some extent
in the Scl1-mediated binding process. To avoid the lack
of interference of the abovementioned monoclonal anti-
bodies in the binding interaction, we employed polyclo-
nal antibodies against a2a n db1 integrins. Polyclonal
antibodies against a2a n db1 integrins significantly
decreased Scl1-mediated adhesion of E. coli to human
epithelial cells (Figure 5C). These results suggest that
protein receptors a2a n db1 integrins underlie the Scl1-
dependent binding to human epithelial cells.
A.                               B .       
           
C. 
 
Figure 4 Adhesion abilities of E. coli to HEp-2 cells. (A) Adhesion of FITC-conjugated ET2, and ET3 to HEp-2 cells. The adhesion ability is
expressed as the ratio of florescence from adherent bacteria to that from inoculated bacteria. Bacteria were treated with proteinase K before
FITC conjugation. Data represent means of five experiments with triplicate samples in each experiment. ET2, E. coli expressing vector only. ET3, E.
coli expressing Scl1. (B) SDS-PAGE and western blot analysis of purified recombinant Scl1 protein. Lane 1 indicates the SDS-PAGE of purified
rScl1. Lane 2 indicates the purified rScl1 protein confirmed by western blot analysis using anti-Scl1 antibody. rScl1 is indicated by a 48 kDa band.
(C) Inhibition of binding by rScl1 protein and anti-Scl1 antibody. Prior to the adhesion assay, HEp-2 cells were pre-treated with rScl1 protein and
ET3 were pre-treated with anti-Scl1 antibody and mouse IgG, respectively. **, P < 0.01 and ***, P < 0.001.
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Page 6 of 11To further examine the Scl1-mediated adhesion of
E. coli to other eukaryotic cell types known for expres-
sion of collagen receptors, we employed two types of
cell lines, C2C12 myoblast and human umbilical vein
endothelial cell (HUVEC) for the adhesion assay. C2C12
cells are known to express b1i n t e g r i n s[ 2 0 ] ,w h e r e a s
primary HUVECs express a2b1 integrins [21]. Our
results show that Scl1-expressed E. coli ET3 exhibited
significantly increased adherence to both C2C12 and
HUVEC cells, compared to control ET2 (Figure 5D).
Thus multiple eukaryotic cell types may bind and
adhere to Scl1-expressed E. coli.
Discussion
The Scl1 protein in the S. pyogenes M29588 strain (M92
type) contains a predicted signal peptidase cleavage site
on Ala38, 71 amino acids in V region, 46 GXX repeats
in CL region, 6 conserved repeats (PGEKAPEKS) in L
region, and followed by a cell wall anchor motif
(LPATGE). It has been proposed that the V-region pri-
mary sequence in Scl1 is M type associated [7]. Based
on the previous study in characterization of the scl1
gene among 21 different M type strains [6], the length
of V region in M92 strain is identical to those in M49
and M56 strains. The number of GXX repeats in CL
region in M92 strain is equal to those in M2 and M49
strains. The number of PGEKAPEKS repeats in L region
in M92 strain is the same with those in M4 and M9
strains. These findings demonstrate significant and
extensive genetic variations among clinical isolates of
S. pyogenes.
Rasmussen et al. demonstrated that an isogenic Scl1-
deficient M1 strain (AP1) with 57 GXX repeats did not
alter its adhesion ability to Detroit 562 pharyngeal cells
A.                                  B .        
      
C.                           D .  
         
Figure 5 Adherence through protein receptors on HEp-2 cells. (A) Adhesion of E. coli to surface-modified HEp-2 cells. HEp-2 cells were pre-
incubated with medium alone, pronase (50 and 500 μg/ml), and phospholipase A2 (200 μg/ml), respectively, prior to the adhesion assay. (B)
Adhesion of E. coli to HEp-2 cells with pre-treatment of monoclonal antibodies (mAb) against a2, b1, and a2b1 integrins. (C) Adhesion of E. coli
to HEp-2 cells with pre-treatment of polyclonal antibodies (pAb) against a2 and b1 integrins. (D) Adhesion of E. coli to C2C12 myoblasts and
HUVECs. Data represent means of five experiments with triplicate samples in each experiment. *P < 0.05, **P < 0.01, and ***P < 0.001.
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Page 7 of 11[5]. In contrast, Lukomski et al. demonstrated that two
independent isogenic Scl1-deficient M1 strains (MGAS
6708 and 5005) with 50 GXX repeats had significantly
reduced adherence to human A549 epithelial cells [6].
Although the differences on the surface of various host
epithelial cells cannot be excluded, this inconsistency
may stem from the carriage of various group A strepto-
coccal adhesins and potential interference of another Scl
family member, Scl2. The role of Scl2 in adhesion has
been directly addressed in another study by Rasmussen
et al. showing that Scl2-deficient isogenic mutants had
decreased adherence to human fibroblast cells, but no
influence on adherence to pharyngeal cells [18]. Thus,
Scl2 appears to be involved in the adhesion process, and
t h ep r e s e n c eo fS c l 2c o u l dt h e r e f o r ep o t e n t i a l l yi n f l u -
ence and mask the effect of Scl1 in the adhesion. How-
ever, Scl2 production in all M1-type strains investigated
so far is early terminated at the level of translation
[7,18]. In our study, we also demonstrated that the S.
pyogenes M29588 strain expresses a pre-terminated Scl2,
which contains neither CL region nor anchor motif,
according to our sequence analysis. These findings sug-
gest that Scl2 in this particular strain is not functional
due to the absence of CL region, and is not anchored
on the cell membrane because of the lack of an anchor
motif. Our adherence results based on this Scl2-
defective S. pyogenes M29588 strain provide evidence for
the contribution of Scl1 on the binding to host epithelial
cells.
While Rasmussen et al. used a Scl2-defective AP1
strain to demonstrate that Scl1 mutation does not affect
adherence of bacteria to pharyngeal cells [5], their study
may have utilized a background where the Scl1 muta-
tion was compensated for by other adhesins, such as
protein H [22], C5a peptidase [23]. In our study, we also
identified the expression of some surface proteins in this
M29588 strain. To exclude the interference of other
streptococcal surface factors during Scl1-mediated adhe-
sion, the heterologous expression of Scl1 on E. coli
would be an alternative. The outer membrane of Gram-
negative bacteria presents an effective barrier that
restricts the release of proteins from the bacteria [24].
Many peptides have been inserted within external loops
of various outer membrane proteins and have been
shown to be exposed on the surface of intact E. coli by
immunochemical techniques [24-26]. In addition, stu-
dies have demonstrated that OmpA chimeric proteins
were stably anchored on the external side of the bacteria
[24,25,27]. Here we demonstrated that truncated Scl1
fused with OmpA was directed to the outer membrane
fraction of E. coli by western blot analysis, and likely
exposed on the surface of E. coli by FACS analysis.
While ectopic expression of Scl1 on the heterologous
bacteria E. coli is an alternative approach to reduce the
potential interference of other factors on the surface of
S. pyogenes, there are some limitations in our study. For
example, it can not be ruled out that Scl1 protein was
secreted to the periplasmic space, because Scl1 was con-
structed after the OmpA signal sequence. To avoid this
problem, we performed FACS analysis on whole bacteria
using Scl1 antibodies to detect the location of Scl1 in/on
E. coli. FACS analysis has been widely used in identifica-
tion of cell surface molecules in many immunologic and
hematologic studies. Furthermore, we isolated proteins
from the outer membrane fraction and confirmed the
existence of Scl1 by western blot analysis with antibo-
dies against Scl1 and its fusion protein OmpA. However,
the proper folding of ectopically expressed Scl1 and the
integrity of the outer membrane of E. coli account for
other issues influencing our interpretation of Scl1 in
adhesion. Nevertheless, our findings concerning the
adherence of Scl1-expressed E. coli to human epithelial
cells unequivocally show that Scl1 contributes signifi-
cantly to the adhesion of bacteria to human epithelial
cells.
Collagen is a triple-helical, elongated protein structure
that is the main structural component of the extra-cellular
matrix in all multicellular organisms. Collagen-like
sequences are found not only in proteins of multicellular
organisms but also in proteins of microorganisms, such as
a pullulanase in Klebsiella pneuminiae [28] and a platelet
aggregation-associated protein in S. sanguis [29,30]. More-
over, collagens interact with several macromolecules in a
specific manner, suggesting that the collagen-like repeat
sequences not only play a basic structural role, but also
have a functional significance. Many eukaryotic cells bind
collagen through integrins expressed on their surface [11].
Studies have demonstrated that the recombinant Scl1.41
protein interacted with a2b1a n da11b1 integrins, induced
intracellular signaling in host cells, and promoted the
internalization of S. pyogenes [9,12,13]. While the hypothe-
sized region mediating the binding to a2b1a n da11b1
integrins in the recombinant Scl1.41 is in a motif called
the GLPGER motif [9,12,13], Scl1 protein of S. pyogenes
M29588 strain in our study does not contain the GLPGER
motif. The novel aspect of this study is the observation
that, in this Scl1 sequence type, the GLPGER motif is
absent, yet adherence is maintained. Nevertheless, our
results indicate that protein receptors, a2a n db1 integrins,
contribute to Scl1-dependent binding to the surface of
human epithelial cells. Consistently, Scl1-mediated adhe-
sion was also demonstrated in other eukaryotic cell types
known for expression of collagen receptors.
Conclusions
In summary, we demonstrated that loss of Scl1 in a
Scl2-defective S. pyogenes strain decreased the adhesion
of bacteria to human epithelial cells. Ectopic expression
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coli promoted the adhesion of bacteria to epithelial cells.
The increase in adhesion was nullified by proteinase K,
rScl1 protein and anti-Scl1 antibody. This binding event
appears to be mediated through protein receptors, a2
and b1 integrins, instead of a lipid component, on the
surface of epithelial cells. Our results underscore the
importance of Scl1 in the adherence of S. pyogenes to
human epithelial cells. Understanding the mechanisms
by which S. pyogenes adheres to nasal epithelial cells
may lead to alternative therapeutic methods of decoloni-
zation and decrease the dependence on antibiotics.
Methods
Bacterial strains and plasmids
S. pyogenes strain M29588 (emm sequence type 92) was
recovered from a patient with necrotizing fasciitis at the
Tzu-Chi General Hospital. S. pyogenes cultures were
g r o w ni nt r y p t i cs o yb r o t hs u p p l e m e n t e dw i t h0 . 5 %
yeast extract (TSBY). E. coli DH5a was grown in Luria
broth (LB). Plasmid pSF151 was kindly provided by Dr.
Tao of the University of Missouri, Kansas City, USA
[31]. Plasmid pST1, which contains the truncated
OmpA fusion protein derived from pCR2.1-TOPO (Invi-
trogen), was kindly provided by Dr. C. Y. Chen of
National Taiwan University, Taipei, Taiwan. ET2 and
ET3 are E. coli DH5a containing plasmids pST1 and
pPJT9, respectively. E. coli was transformed according to
the method of Sambrook et al. [32]. S. pyogenes was
electroporated according to the method of Schalen et al.
[31].
Cloning of scl1 and scl2
The internal scl1 gene was amplified by PCR using S.
pyogenes M29588 DNA as a template with the primers
of scl1-4 (5’-AACTGCAGCCTTTTTCACCCTTTTC
GCC-3’)a n dscl1-5 (5’-GGGGTACCTTTGGAGG
CGGGGCAAGCA-3’), while the full-length scl1 gene
was amplified by primers of scl1-6 (5’-TCCCCC
GGGATGTTGACATCAAAGCAC-3’)a n dscl1-7 (5’-
TCCCCCGGGTTAGTTGTTTTCTTTGCG-3’) based
on the previously published sequence [6]. Primers of
scl2-3 (5’-GTGAACAAAACAAAA-3’)a n dscl2-4 (5’-
TTAGTTGTTTTCTTG-3’), obtained from the Strepto-
coccal Genome Sequencing database, were used to
amplify the scl2 gene. The underlined sequences repre-
sent the restriction sites. After amplification, the 0.5-kb
internal scl1 PCR product was digested with KpnIa n d
PstI, and inserted into plasmid pSF151 to generate plas-
mid pPJT8. Truncated Scl1 from V region to part of L
region was amplified by primers of scl1-8 (5’-
TCCCCCGGGGAGACTCCTATGACATCA-3’)a n d
scl1-2 (5’-TCCCCCGGGTTTGGTTAGCTTCTTTGTC-
3’), digested with SmaI ,a n di n s e r t e di n t oO m p A -
containing vector pST1 to generate plasmid pPJT9. The
construction was analyzed by endonuclease digestion
and DNA sequencing (ABI-3730 auto-sequencer,
Applied Biosystems). The 1.5-kb fragment of scl2 gene
was analyzed directly by DNA sequencing. The scl1 and
scl2 sequences reported here were deposited in GenBank
under accession numbers DQ166850 and DQ166851.
Bacterial RNA extraction and RT-PCR
Extraction of total RNA was done as described previously
with slight modification [33]. Briefly, bacteria were har-
vested, washed, resuspended with buffer containing lyso-
zyme and mutanolysin, and incubated to weaken cell
walls. Bacterial pellets were collected and resuspended.
Extraction of RNA was done by mixing with hot phenol
followed by vortex and centrifugation. The upper aqueous
phase was collected and precipitated. RNA was treated
with DNase and re-extracted again. 1 μg extracted RNA
was reverse-transcribed to cDNA in total 20 μl reactive
solution by Improm II RT kit (Promega). The expression
of sfb, prtF1, oppA, speB, scl1,a n dscl2 was assessed by
PCR with primers sfb-1 (CCTCTAGCGGGTGAGTCT),
sfb-2 (AATGGAACACTGAATTCGGACGGG), prtF1-1
(TTTTCAGGAAATATGGTTGAGACA), prtF1-2 (TCG
CCGTTTCACTGAAACCACTCA), oppA-1 (TGGT
ATACGGCTGATGGTGA), oppA-2 (GCTTTCTT ACC
GGCATCTTG), speB-1 (TGATGGCTGATGTTGG
TATTTC), speB-2 (ATTCTTTGTCAATTTGTGCT
TCC), scl1-6 (ATGTTGACATCAAAGCAC), scl1-4
(CCTTTTTCACCCTTTTCGCC), scl2-1 (TGCTGACCT
TTGGAGGTGC), and scl2-2 (CGCCTGTTGCTGGCA
ATTGTC). Genomic DNA was used as a positive control
to confirm the size of PCR product, and the extracted
RNA was used as a negative control to exclude the possi-
bility of DNA contamination.
Adhesion assay
Human epidermoid carcinoma epithelial cells (HEp-2;
ATCC CCL-23) and C2C12 mouse myoblasts (ATCC
CRL-1772) were cultured in DMEM supplemented with
10% FCS. HUVECs were cultured on 0.04% gelatin-coated
(Sigma) plates in M199 supplemented with 2 mM L-gluta-
mine (Invitrogen), 10% FBS, and 25% EGM. Adhesion of
FITC-conjugated bacteria to cells was measured using a
previously described method with slight modifications
[34,35]. Bacteria were suspended in cell culture medium
to a density of 4 × 10
8 cells/ml. FITC-conjugated bacterial
suspension was added to the confluence cells at a M.O.I.
of 100 and incubated for 2 hrs at 37°C. The fluorescence
of each well was measured by a CytoFluor II flourescence
reader (Millipore) with excitation and detection wave-
length of 485 nm and 530 nm, respectively. Compared to
the results from the conventional plating experiment, the
FITC conjugation did not affect the adherence of bacteria.
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For the proteolytic treatment of bacteria, the bacterial
suspension (10
8 CFU/ml) was incubated with proteinase
K( 1 0μg/ml) for 1 h at 37°C. The suspension was
washed and re-suspended in 1 ml of PBS for the subse-
quent FITC-conjugation and adhesion assay. In the anti-
body blocking assay, FITC-conjugated bacteria was
incubated with anti-Scl1 antibody (10 μg/ml) for 30 min
at room temperature. In the recombinant protein block-
ing assay, HEp-2 cells were pre-incubated with recombi-
nant Scl1 protein (10 μg/ml), and subsequently
incubated with FITC-conjugated bacteria for the adhe-
sion assay. To enzymatically modify cell surface pro-
teins, confluence HEp-2 cells were incubated with
pronase (500 and 50 μg/ml; Sigma) or phospholipase A2
(200 μg/ml; Sigma) in FCS-free DMEM for 30 min at
37°C, washed twice with PBS, and then incubated with
FITC-conjugated bacteria for the adhesion assay. For
the integrin blocking assay, confluence HEp-2 cells were
incubated with antibodies (10 μg/ml) against a2 (P1E6,
monoclonal, Chemicon International; P17301, polyclo-
nal, Millipore), b1 (P4G1, monoclonal, Chemicon Inter-
national; P05556, polyclonal, Millipore), a2b1( B H A 2 . 1 ,
monoclonal, Chemicon International) integrins and
mouse IgG (Sigma) for 30 min before the incubation
with FITC-conjugated bacteria for the adhesion assay.
Electron microscopy
Drops of bacterial suspension fixed with 2.5% glutaralde-
hyde were concentrated and placed on formvar-coated
copper grids for 1 min. After removal of excess fluid by
placing on filter paper, the wet residues were immedi-
ately covered with the stain for 30 sec. The grid was air-
dried before examination for negative staining electron
microscopy.
FACS analysis
Surface-detection of Scl1 in E. coli was performed by
FACS analysis. Approximately 1 × 10
7 bacteria were
incubated with mouse anti-Scl1 antibody (1:1000) for
1 hr and subsequently with FITC-conjugated goat anti-
mouse IgG (1:1000, Amersham Biosciences) for 30 min.
The fluorescence of adhered bacteria was analyzed by a
FACS-Scan flow cytometer (Beckton-Dickinson).
Surface protein isolation
Outer membrane proteins were isolated from bacteria
cultures according to a protocol by Fountoulakis and
Gasser [36]. Briefly, the overnight E. coli culture was pel-
leted and the bacteria were resuspended. After shacking
and a centrifugation, the new pellet was resuspended and
disrupted 3 times by sonication. To remove unbroken
cells and debris, sonicated bacteria were centrifuged at
3,000 rpm and subsequently the supernatants were cen-
trifuged at 90,000 rpm. To solubilize the inner membrane
protein, the pellet was incubated with 2 ml 2% sodium
N-laung sarcosinate and subsequently the supernatants
were centrifuged at 90,000 rpm. The pelleted outer mem-
brane proteins were resuspended. OmpA expression pat-
tern performed by western blot using anti-OmpA
antibody was represented as an internal control.
Recombinant protein and preparation of antibody
The 1.3-kb full-length sc1l gene was cloned into plasmid
pQE30 to construct plasmid pPJ10. The recombinant
protein was expressed after isopropyl-b-D-thiogalacto-
pyranoside induction. The expressed protein containing
the His6 tag was separated in a Ni-chelated column
(Amersham Biosciences) and eluted by a 0 to 50 mM
imidazole gradient. The purified protein was verified by
SDS-PAGE and western blot analysis with anti-His
monoclonal antibody (Invitrogen). Antibody against puri-
fied rScl1 was raised in 4-week-old BALB/c mice. One
hundred microgram of rScl1 was applied in the initial
immunization of BALB/c mice, with succeeding injec-
tions 2 and 4 wks thereafter. Anti-Scl1 mouse IgGs were
enriched and purified by affinity chromatography with a
column made of Sepharose conjugated to protein A.
Data analysis
Values were reported as mean ± SEM. Statistical analy-
sis was conducted using JMP software (SAS Institute).
Student’s t-test was used for comparisons between
groups and differences were considered to be statisti-
cally significant with P value less than 0.05.
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